Using mobile health to improve care for people with HIV, mental illness, and high blood pressure in Uganda
An mHealth implementation strategy to address the syndemic of mental illness, hypertension, and HIV in Uganda
This study is working to help people with HIV in Uganda by using mobile technology to make it easier for doctors to support them with both mental health and high blood pressure, so they can get the personalized care they need right on their phones.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10928182 on NIH RePORTER |
What this research studies
This research aims to improve the health outcomes of individuals living with HIV in Uganda by addressing the co-occurring issues of mental illness and hypertension. It utilizes mobile health technology to streamline healthcare delivery, making it easier for healthcare workers to manage these interconnected conditions. By focusing on the social factors that exacerbate these health issues, the study seeks to create a more integrated and effective care model. Patients will benefit from a system that recognizes the complexity of their health needs and provides tailored support through their mobile devices.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV in Uganda who also experience mental health issues or hypertension.
Not a fit: Patients who do not have HIV or do not experience mental health issues or hypertension may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health management for patients living with HIV, mental illness, and hypertension, enhancing their overall quality of life.
How similar studies have performed: Previous research has shown that mobile health interventions can effectively improve health outcomes in similar populations, indicating a promising approach.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Schwartz, Jeremy Ian — Yale University
- Study coordinator: Schwartz, Jeremy Ian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.